Stock Analysis

Ancom Nylex Berhad Full Year 2024 Earnings: Misses Expectations

KLSE:ANCOMNY

Ancom Nylex Berhad (KLSE:ANCOMNY) Full Year 2024 Results

Key Financial Results

  • Revenue: RM2.00b (down 2.3% from FY 2023).
  • Net income: RM81.5m (up 8.4% from FY 2023).
  • Profit margin: 4.1% (up from 3.7% in FY 2023). The increase in margin was driven by lower expenses.
  • EPS: RM0.086 (up from RM0.084 in FY 2023).
KLSE:ANCOMNY Revenue and Expenses Breakdown October 3rd 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ancom Nylex Berhad Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 5.1%. Earnings per share (EPS) also missed analyst estimates by 6.6%.

The primary driver behind last 12 months revenue was the Industrial Chemicals segment contributing a total revenue of RM1.29b (65% of total revenue). Notably, cost of sales worth RM1.68b amounted to 84% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to RM102.6m (44% of total expenses). Explore how ANCOMNY's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Chemicals industry in Malaysia.

Performance of the Malaysian Chemicals industry.

The company's shares are down 2.9% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for Ancom Nylex Berhad that you need to take into consideration.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.